External penile rigidity device OTC sales via 510(k) sanctioned in revised FDA policy.
This article was originally published in The Gray Sheet
Executive Summary
EXTERNAL PENILE RIGIDITY DEVICES: OVER-THE-COUNTER SALES for use in treating or managing erectile dysfunction require 510(k) review and adequate labeling for the layperson, FDA says in a Sept. 10 interim policy on constriction rings, vacuum erection systems and penile splint products that allows OTC sales of the devices for the first time. The devices previously were made available for medical use only with a physician prescription.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.